Trial intelligence / Profile preview

Safety Study of IMOVAX Polio in China

NCT01244464Phase 4Completed

Sponsor
Sanofi
Start
Nov 2010
Primary completion
Jun 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of inactivated poliovirus vaccine in poliomyelitis, sponsored by Sanofi. Started Nov 2010; status: completed.

02

Drugs

inactivated poliovirus vaccine
03

Conditions

poliomyelitis

Beyond the preview

Go deeper on NCT01244464.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01244464.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call